Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #107470 on Biotech Values
DewDiligence
10/28/10 10:20 PM
#107479 RE: acgood #107470
…MAXY stands to reap another $65-123M…for the pharmaceutical application of the technology if Astellas buys out the Perseid joint venture that holds the molecular breeding license for therapeutics.